AR035679A1 - Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los - Google Patents
Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de losInfo
- Publication number
- AR035679A1 AR035679A1 ARP020100030A ARP020100030A AR035679A1 AR 035679 A1 AR035679 A1 AR 035679A1 AR P020100030 A ARP020100030 A AR P020100030A AR P020100030 A ARP020100030 A AR P020100030A AR 035679 A1 AR035679 A1 AR 035679A1
- Authority
- AR
- Argentina
- Prior art keywords
- sales
- pharmaceutically acceptable
- compounds
- acid
- difluorpirrolidinil
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000012902 Nervous system disease Diseases 0.000 title abstract 2
- 208000025966 Neurological disease Diseases 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- 230000000926 neurological effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 5
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035679A1 true AR035679A1 (es) | 2004-06-23 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020100030A AR035679A1 (es) | 2001-01-05 | 2002-01-04 | Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (cs) |
| JP (1) | JP2004520335A (cs) |
| KR (1) | KR20030066797A (cs) |
| CN (1) | CN1484642A (cs) |
| AR (1) | AR035679A1 (cs) |
| BR (1) | BR0116672A (cs) |
| CA (1) | CA2431545A1 (cs) |
| CZ (1) | CZ20031856A3 (cs) |
| DZ (1) | DZ3460A1 (cs) |
| EA (1) | EA200300770A1 (cs) |
| EC (1) | ECSP034682A (cs) |
| HR (1) | HRP20030544A2 (cs) |
| HU (1) | HUP0302528A2 (cs) |
| IL (1) | IL156138A0 (cs) |
| MX (1) | MXPA03005981A (cs) |
| NO (1) | NO20032973D0 (cs) |
| NZ (1) | NZ525821A (cs) |
| PE (1) | PE20020792A1 (cs) |
| PL (1) | PL361934A1 (cs) |
| SK (1) | SK8242003A3 (cs) |
| TW (1) | TW591023B (cs) |
| WO (1) | WO2002053561A1 (cs) |
| ZA (1) | ZA200304311B (cs) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| CA2319652A1 (en) * | 1998-02-06 | 1999-08-12 | Michael Urquhart | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| EP1200073B1 (en) * | 1999-07-06 | 2007-01-10 | Eli Lilly And Company | SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
-
2001
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ3460A1 (fr) | 2002-07-11 |
| MXPA03005981A (es) | 2003-09-10 |
| NZ525821A (en) | 2004-07-30 |
| BR0116672A (pt) | 2003-09-23 |
| TW591023B (en) | 2004-06-11 |
| SK8242003A3 (en) | 2004-01-08 |
| ZA200304311B (en) | 2004-09-02 |
| CA2431545A1 (en) | 2002-07-11 |
| NO20032973L (no) | 2003-06-27 |
| NO20032973D0 (no) | 2003-06-27 |
| KR20030066797A (ko) | 2003-08-09 |
| IL156138A0 (en) | 2003-12-23 |
| CZ20031856A3 (cs) | 2003-09-17 |
| EP1351955A1 (en) | 2003-10-15 |
| WO2002053561A1 (en) | 2002-07-11 |
| JP2004520335A (ja) | 2004-07-08 |
| HUP0302528A2 (hu) | 2003-11-28 |
| CN1484642A (zh) | 2004-03-24 |
| EA200300770A1 (ru) | 2003-10-30 |
| PL361934A1 (en) | 2004-10-18 |
| PE20020792A1 (es) | 2002-09-06 |
| HRP20030544A2 (en) | 2004-08-31 |
| ECSP034682A (es) | 2003-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034712A (es) | Ciclobuteno-1.2-dionas 3,4-di-substituidas como antagonistas del receptor quimiocina cxc | |
| ECSP034640A (es) | Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato | |
| ECSP034744A (es) | Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos | |
| CR9910A (es) | Antagonistas del receptor 3 de la histamina | |
| BRPI0415657A (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
| BR0104834A (pt) | Moduladores de receptores de glucocorticóides | |
| AR047992A1 (es) | Diaminopirimidinas como antagonistas de p2x3 y p2x2/3 | |
| UY29710A1 (es) | Benzimidazoles tricíclicos y su uso como moduladores de receptores metabotrópicos de glutamato | |
| PE20010205A1 (es) | Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato | |
| EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
| AR028824A1 (es) | Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos. | |
| AR040278A1 (es) | Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos | |
| ECSP056134A (es) | Derivados de quinuclidina que se enlazan con los receptores muscarínicos m3 | |
| DE60120077D1 (de) | Modulatoren des Glucocorticoid-Rezeptors | |
| AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
| ES2156287T3 (es) | Derivados de difenilmetilen piperidina. | |
| CL2004000769A1 (es) | Compuestos derivados del acido [2-(8,9-dioxo-2,6-diazabiciclo [5,2,o]non-1-(7)-en-2-il) alquil]fosfonico, antagonistas del receptor n-metil-d-aspartato (nmda); procedimiento de preparacion; composicion farmaceutica; y su uso para tratar desordenes va | |
| ECSP056115A (es) | ANTAGONISTAS DEL RECEPTOR A2a DE 2-ALQUINIL- Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA ADENOSINA | |
| BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| UY26919A1 (es) | Derivados de la quinazolina como antagonistas adrenérgicos alfa - 1 | |
| ES2092646T3 (es) | Metanoantracenos como antagonistas de dopamina. | |
| ECSP056192A (es) | 3-fluoro-piperidinas como antagonistas de nmda/nr2b | |
| YU75603A (sh) | Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja | |
| CY1112227T1 (el) | Πιπεριδινυλαμινο-πυριδαζινες και η χρηση τους ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FA | Abandonment or withdrawal |